Reprocell Inc operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Reprocell Inc with three other
pharmaceutical manufacturers in Asia:
Gujarat Themis Biosyn Limited
sales of 851.24 million Indian Rupees [US$11.57 million]
Natural Capsules Limited
(615.55 million Indian Rupees [US$8.37 million]
Nutraplus India Ltd
based in INDIA
(1.07 billion Indian Rupees [US$14.50 million]
During the year ended March of 2020, sales at
Reprocell Inc were ¥1.20 billion (US$11.47 million).
increase of 10.2%
versus 2019, when the company's sales were ¥1.09 billion.
Sales of Research Support Business saw an increase
20.0% in 2020, from
¥934.21 million to ¥1.12 billion.
Not all segments of Reprocell Inc experienced an increase in sales in 2020:
sales of Medical Business fell 48.6% to ¥79.30 million.